SEATTLE, May 31, 2012 /PRNewswire-iReach/ -- Global BioClinical (GBC) is pleased to announce the addition of Jennifer Maas to the corporate team. Ms. Maas has joined GBC as a Senior Consultant and Clinical Operations Manager. Formerly a Clinical Research Manager at Epigenomics, Inc., Ms. Maas joins GBC with 10+ years of experience, having been responsible for a variety of clinical research studies, international biorepository operations, and biospecimen informatics.
"We are delighted to have Jen join the team and look forward to her important contributions. She brings a wealth of proven experience from successfully managing studies for several molecular diagnostic products," says Neil R. Mucci, CEO.
About Global BioClinical:
Global BioClinical (GBC) is a contract consulting and clinical research organization (CRO) with core expertise in organizational and project management, clinical trial planning and execution, and human biospecimens. GBC works with clients in the life sciences and healthcare research sector including early-stage and established medical device and biotechnology companies, pharmaceutical companies, medical centers and health systems, research and academic institutions, government agencies and sub-contractors, venture capital groups, and not-for-profit groups. GBC supports predictive, prognostic, personalized, and participatory medicine with the leading goal of moving healthcare products to the market more quickly, with less risk, and with a greater return on investment.
GBC – GLOBAL BIOCLINICAL
Expertise-Based Clinical Research Services
Consulting – Business – Trials – Biospecimens
93 S. Jackson St.
Seattle, WA 98104-2818 U.S.A.
Main: +1 888 659 1221
Linked In: www.linkedin.com/company/global-bioclinical
Media Contact: GBC Press Global BioClinical, 888-659-1221, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
|SOURCE Global BioClinical|
Copyright©2010 PR Newswire.
All rights reserved